Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Rockwell Medical (RMTI) Shares Outstanding (Weighted Average) (2017 - 2025)

Historic Shares Outstanding (Weighted Average) for Rockwell Medical (RMTI) over the last 11 years, with Q3 2025 value amounting to $36.0 million.

  • Rockwell Medical's Shares Outstanding (Weighted Average) rose 1417.71% to $36.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $36.0 million, marking a year-over-year increase of 1417.71%. This contributed to the annual value of $31.1 million for FY2024, which is 3316.75% up from last year.
  • As of Q3 2025, Rockwell Medical's Shares Outstanding (Weighted Average) stood at $36.0 million, which was up 1417.71% from $34.3 million recorded in Q2 2025.
  • Rockwell Medical's 5-year Shares Outstanding (Weighted Average) high stood at $36.0 million for Q3 2025, and its period low was $8.5 million during Q1 2021.
  • Over the past 5 years, Rockwell Medical's median Shares Outstanding (Weighted Average) value was $18.5 million (recorded in 2023), while the average stood at $21.1 million.
  • As far as peak fluctuations go, Rockwell Medical's Shares Outstanding (Weighted Average) plummeted by 8872.52% in 2021, and later skyrocketed by 11633.55% in 2022.
  • Quarter analysis of 5 years shows Rockwell Medical's Shares Outstanding (Weighted Average) stood at $8.5 million in 2021, then soared by 67.77% to $14.3 million in 2022, then surged by 63.05% to $23.3 million in 2023, then surged by 33.17% to $31.1 million in 2024, then grew by 15.99% to $36.0 million in 2025.
  • Its Shares Outstanding (Weighted Average) was $36.0 million in Q3 2025, compared to $34.3 million in Q2 2025 and $34.1 million in Q1 2025.